7-OH (7-Hydroxymitragynine): Federal Status (2026)

Not federally scheduled

7-OH: not yet scheduled; DEA re-noticed Oct 14 (Schedule I above 1 mg/g or under 100:1 mitragynine ratio) on or after Nov 13

Verified September 22, 2026
21 CFR 1308.11 Schedule I (eCFR, current as of 2026-09-22): paragraphs (h)(89)-(91) list mitragynine pseudoindoxyl, MGM-15 and MGM-16 (added 91 FR 54948, eff. 2026-08-26). No paragraph lists 7-hydroxymitragynine; the July 6, 2026 notice of intent proposed 'Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I' and remains a proposal.

Citations

  1. 21 CFR 1308.11 Schedule I (eCFR, current) (eCFR / Office of the Federal Register, 2026-09-22) PRIMARYOFFICIAL
  2. Schedules of Controlled Substances: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I (notice of intent, 2026-07-06; comment period extended 2026-08-26) (Drug Enforcement Administration / Federal Register, 2026-09-22) PRIMARYOFFICIAL
  3. Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I (DEA temporary scheduling order, 91 FR 54948, Docket No. DEA-1644, FR Doc. 2026-17429) (Drug Enforcement Administration / Federal Register, 2026-09-22) PRIMARYOFFICIAL

Change history

  • Headline updated: "7-OH: not yet scheduled; DEA re-noticed Oct 14 (Schedule I above 1 mg/g or under 100:1 mitragynine ratio) on or after Nov 13".

Pending deadlines

  • 2026-08-01 · Federal · DEA temporary Schedule I order for 7-OH (above threshold) - effective on Federal Register publication (DEA NOI 2026-07-01)
  • 2026-08-05 · Federal · DEA temporary Schedule I - 7-OH above a specified threshold (DEA-1570 / FR 2026-13580)
  • 2026-11-13 · Federal · DEA temporary Schedule I: 7-OH above 1 mg/g or under 100:1 mitragynine ratio (re-notice) (DEA-1570 / FR 2026-20943)

Federal instruments on file

21 CFR 1308.11(h)(89)-(91) (temporary, 91 FR 54948) · Temporary placement of mitragynine pseudoindoxyl, MGM-15 and MGM-16 in Schedule I - amendatory textOFFICIAL
Instrument
Temporary placement of mitragynine pseudoindoxyl, MGM-15 and MGM-16 in Schedule I - amendatory text
Source
https://www.federalregister.gov/documents/2026/08/26/2026-17429/schedules-of-controlled-substances-temporary-placement-of-mitragynine-pseudoindoxyl-mgm-15-and
Retrieved
2026-09-22
Fingerprint
fa16cebdc1144cd6
For the reasons set out above, DEA amends 21 CFR part 1308 as 
follows:
PART 1308--SCHEDULES OF CONTROLLED SUBSTANCES
0
1. The authority citation for part 1308 continues to read as follows:
 Authority: 21 U.S.C. 811, 812, 871(b), 956(b), unless otherwise 
noted.
0
2. In Sec. 1308.11, add paragraphs (h)(89) through (91) to read as 
follows:
Sec. 1308.11 Schedule I.
* * * * *
 (h) * * *
------------------------------------------------------------------------
 * * * * * * *
(89) Methyl (E)-2-((1'S,6'S,7'S)-6'-ethyl-4-methoxy-3-oxo- 9672
 3',5',6',7',8',8a'-hexahydro-2'H-spiro[indoline-2,1'-
 indolizine]-7'-yl)-3-methoxyacrylate (commonly known as
 mitragynine pseudoindoxyl) including its isomers, esters,
 ethers, salts, and salts of isomers, esters, and ethers,
 whenever the existence of such isomers, esters, ethers, and
 salts is possible. Since nomenclature of this substance is not
 internationally standardized, compounds of this structure,
 regardless of numerical designation of atomic positions are
 covered
(90) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8- 9673
 methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-
 a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-
 15; also known as dihydro-7-hydroxymitragynine) including its
 isomers, esters, ethers, salts, and salts of isomers, esters,
 and ethers, whenever the existence of such isomers, esters,
 ethers, and salts is possible. Since nomenclature of this
 substance is not internationally standardized, compounds of
 this structure, regardless of numerical designation of atomic
 positions are covered
(91) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-7a- 9674
 hydroxy-8- methoxy-1,2,3,4,6,7,7a,12,12a,12b-
 decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate
 (commonly known as MGM-16; also known as 9-fluoro-dihydro-7-
 hydroxymitragynine; or 10-fluoro-dihydro-7-hydroxymitragynine
 (depending on numbering convention)) including its isomers,
 esters, ethers, salts, and salts of isomers, esters, and
 ethers, whenever the existence of such isomers, esters,
 ethers, and salts is possible. Since nomenclature of this
 substance is not internationally standardized, compounds of
 this structure, regardless of numerical designation of atomic
 positions are covered
------------------------------------------------------------------------

Related

7-OH (7-Hydroxymitragynine) by state · How federal precedence works · Temporary scheduling

Cite this page

Compound Analytics. "7-OH (7-Hydroxymitragynine): Federal Status (2026)." Compound Laws, https://compoundlaws.com/compounds/7-oh/federal/. Accessed October 25, 2026.

Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.

About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap